Drug General Information (ID: D0910)
  Drug Name
Levamisole
  Drug Type Small molecule
  Drug Synonymous
Ketrax; LEVOMYSOL; Lepuron; Levamisol; Levamisolum; Levotetramisole; Tetramisol; Wormicid; Levamisole Base;Nilverm base; P00039; Vermisol 150; Dl-Tetramisol; Dl-Tetramisole; Ergamisol (TN); Ketrax (TN); L-Tetramisole; Levamisol [INN-Spanish]; Levamisole (INN); Levamisole [INN:BAN]; Levamisolum [INN-Latin]; TCMDC-125847; L(-)-Levamisole; L-2,3,5,6-Tetrahyro-6-phenylimidazo(2,1-b)thiazole; (-)-Tetramisole; (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole; (S)-(-)-Levamisole
    Click to Show/Hide
  Disease Class 1D0Y-1G2Z: Parasitic infection; 2B90: Colon cancer
  Therapeutic Class Antineoplastics
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C11H12N2S
  InChI 1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1
  InChIKey HLFSDGLLUJUHTE-SNVBAGLBSA-N
  Canonical SMILES C1CSC2=NC(CN21)C3=CC=CC=C3
  External Link
Pubchem ID 26879
CAS Number 14769-73-4
CHEBI ID 6432
TTD ID D0CF2Q
INTEDE ID DR2400

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM043  Additive immunosuppressive effects
BM044  Additive myelosuppressive effects
BM100  Antagonize the effect of vaccine/toxoid
BM105  Antagonize the effect of probiotics
BM106  Diminish the response to diagnostic skin test antigens
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Levamisole
      Pharmacodynamic additive effects
   Additive immunosuppressive effects Drug Num:  36
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0023
 
Adalimumab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3], [4], [5], [6]
D0348
 
Cladribine
 
C10H12ClN5O3
 
20279 
Major    Inter Info   
[7], [8]
D0614
 
Etanercept
 
NA
 
NA
Major    Inter Info   
[1], [2], [3], [4], [5], [6]
D0802
 
Infliximab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3], [4], [5], [6]
D0146
 
Baricitinib
 
C16H17N7O2S
 
44205240 
Major    Inter Info   
[11], [7], [12]
D0304
 
Certolizumab pegol
 
NA
 
NA
Major    Inter Info   
[1], [5], [6]
D0661
 
Fingolimod
 
C19H33NO2
 
107970 
Major    Inter Info   
[15]
D0736
 
Golimumab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3], [4], [5], [6]
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[16], [17]
D1211
 
Ozanimod
 
C23H24N4O3
 
52938427 
Major    Inter Info   
[7], [21]
D1474
 
Siponimod
 
C29H35F3N2O3
 
44599207 
Major    Inter Info   
[11], [22]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[16], [17]
D1600
 
Tofacitinib
 
C16H20N6O
 
9926791 
Major    Inter Info   
[24]
D1666
 
Upadacitinib
 
C17H19F3N6O
 
58557659 
Major    Inter Info   
[25]
D1111
 
Natalizumab
 
NA
 
NA
Major    Inter Info   
[26]
D0032
 
Alefacept
 
NA
 
NA
Moderate    Inter Info   
[27], [28], [29]
D0033
 
Alemtuzumab
 
NA
 
NA
Moderate    Inter Info   
[30]
D0085
 
Anakinra
 
C20H23N5O7S2
 
146171046 
Moderate    Inter Info   
[31], [32], [33]
D0313
 
Chloramphenicol
 
C11H12Cl2N2O5
 
5959 
Moderate    Inter Info   
[11], [7], [34]
D0314
 
Chloramphenicol (ophthalmic)
 
C11H12Cl2N2O5
 
5959 
Moderate    Inter Info   
[11], [7], [34]
D0136
 
Azathioprine
 
C9H7N7O2S
 
2265 
Moderate    Inter Info   
[11], [7]
D0246
 
Canakinumab
 
NA
 
NA
Moderate    Inter Info   
[31], [32], [33]
D0443
 
Denosumab
 
NA
 
NA
Moderate    Inter Info   
[40]
D0499
 
Dimethyl fumarate
 
C6H8O4
 
637568 
Moderate    Inter Info   
[41]
D0507
 
Diroximel fumarate
 
C11H13NO6
 
73330464 
Moderate    Inter Info   
[41]
D1085
 
Monomethyl fumarate
 
C5H6O4
 
5369209 
Moderate    Inter Info   
[41]
D1162
 
Ocrelizumab
 
NA
 
NA
Moderate    Inter Info   
[47]
D1167
 
Olaparib
 
C24H23FN4O3
 
23725625 
Moderate    Inter Info   
[7], [48]
D1174
 
Omacetaxine mepesuccinate
 
C29H39NO9
 
285033 
Moderate    Inter Info   
[49]
D1403
 
Rilonacept
 
NA
 
NA
Moderate    Inter Info   
[31], [32], [33]
D1422
 
Roflumilast
 
C17H14Cl2F2N2O3
 
449193 
Moderate    Inter Info   
[7], [50]
D1509
 
Strontium chloride Sr-89
 
Cl2Sr
 
5388879 
Moderate    Inter Info   
[11], [7], [51]
D1610
 
Topotecan
 
C23H23N3O5
 
60700 
Moderate    Inter Info   
[52]
D1671
 
Ustekinumab
 
NA
 
NA
Moderate    Inter Info   
[56]
D1855
 
Palifermin
 
NA
 
NA
Moderate    Inter Info   
[57]
D1720
 
Zidovudine
 
C10H13N5O4
 
35370 
Moderate    Inter Info   
[11], [7], [60]
   Additive myelosuppressive effects Drug Num:  4
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0370
 
Clozapine
 
C18H19ClN4
 
135398737 
Major    Inter Info   
[7], [9], [10]
D0433
 
Deferiprone
 
C7H9NO2
 
2972 
Major    Inter Info   
[11], [13], [14]
D0710
 
Ganciclovir
 
C9H13N5O4
 
135398740 
Moderate    Inter Info   
[11], [7], [42], [43]
D1676
 
Valganciclovir
 
C14H22N6O5
 
135413535 
Moderate    Inter Info   
[11], [7], [42], [43]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of vaccine/toxoid Drug Num:  14
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1839
 
Measles virus vaccine live attenuated
 
NA
 
NA
Major    Inter Info   
[18], [19], [20]
D1881
 
Rotavirus vaccine
 
NA
 
NA
Major    Inter Info   
[18], [19], [20]
D1897
 
Talimogene laherparepvec
 
NA
 
NA
Major    Inter Info   
[23]
D1914
 
Typhoid vaccine (live)
 
NA
 
NA
Major    Inter Info   
[18], [19], [20]
D1920
 
Varicella Zoster Vaccine (Recombinant)
 
NA
 
NA
Major    Inter Info   
[18], [19], [20]
D1922
 
Yellow Fever Vaccine
 
NA
 
NA
Major    Inter Info   
[18], [19], [20]
D0089
 
Anthrax vaccine
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D0366
 
Clostridium tetani toxoid antigen (formaldehyde inactivated)
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D0756
 
Hepatitis B Vaccine (Recombinant)
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D0767
 
Human papillomavirus type 11 L1 capsid protein antigen
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D0803
 
Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D0804
 
Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D0999
 
Meningococcal polysaccharide vaccine group C
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
D1307
 
Poliovirus type 1 antigen (formaldehyde inactivated)
 
NA
 
NA
Moderate    Inter Info   
[27], [38], [39]
   Antagonize the effect of probiotics Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1827
 
Lactobacillus acidophilus
 
NA
 
NA
Moderate    Inter Info   
[44], [45], [46]
   Diminish the response to diagnostic skin test antigens Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1912
 
Trichophyton mentagrophytes
 
NA
 
NA
Moderate    Inter Info   
[53], [54], [55]
D1913
 
Tuberculin purified protein derivative
 
NA
 
NA
Moderate    Inter Info   
[53], [54], [55]
   Attenuated pharmacological effects (Unspecific) Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0659
 
Filgrastim
 
NA
 
NA
Moderate    Inter Info   
[35], [36], [37]
D1235
 
Pegfilgrastim
 
C27H46N4O19
 
70683024 
Moderate    Inter Info   
[58], [59]
D1446
 
Sargramostim
 
NA
 
NA
Moderate    Inter Info   
[35], [36], [37]
References
1 Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2 Product Information. Enbrel (etanercept). Wyeth-Ayerst Laboratories, Philadelphia, PA.
3 Product Information. Humira (adalimumab). Abbott Pharmaceutical, Abbott Park, IL.
4 Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
5 Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
6 FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
7 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
8 Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
9 Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
10 Canadian Pharmacists Association "e-CPS."
11 Cerner Multum, Inc. "Australian Product Information.".
12 Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
13 Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
14 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
15 Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
16 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
17 Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
18 Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
19 Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
20 Product Information. YF-Vax (yellow fever vaccine). sanofi pasteur, Swiftwater, PA.
21 Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
22 Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
23 Product Information. Imlygic (talimogene laherparepvec). Amgen USA, Thousand Oaks, CA.
24 Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
25 Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
26 Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
27 CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
28 Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
29 Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
30 Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
31 Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
32 Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
33 Product Information. Kineret (anakinra). Amgen, Thousand Oaks, CA.
34 Sim SM, Back DJ, Breckenridge AM "The effect of various drugs on the glucuronidation of zidovudine (azidothymidine AZT) by human liver microsomes." Br J Clin Pharmacol 32 (1991): 17-21. [PMID: 1909542]
35 Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
36 Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
37 Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
38 Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
39 Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
40 Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
41 Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
42 Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
43 Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
44 Borriello SP, Hammes WP, Holzapfel W, et.al "Safety of probiotics that contain lactobacilli or bifidobacteria." Clin Infect Dis 36 (2003): 775-80. [PMID: 12627362]
45 Schlegel L, Lemerle S, Geslin P "Lactobacillus species as opportunistic pathogens in immunocompromised patients." Eur J Clin Microbiol Infect Dis 17 (1998): 887-8. [PMID: 10052559]
46 Salminen MK, Tynkkynen S, Rautelin H, et al. "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis 35 (2002): 1155-60. [PMID: 12410474]
47 Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
48 Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
49 Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
50 Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
51 Multum Information Services, Inc. Expert Review Panel.
52 Product Information. Hycamtin (topotecan). SmithKline Beecham, Philadelphia, PA.
53 Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
54 Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
55 Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
56 Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
57 Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
58 Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
59 Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
60 Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.